1. Almon RR, Andrew CG, Appel SH (1974) Serum globulin in Myasthenia gravis: inhibition of α-bungarotoxin binding to acetylcholine receptors. Science 186:55–57
2. Barkas T, McPhail Gairns J, Jackson Kerr H, Coggins JR, Simpson JA (1982) α-Bungarotoxin binding to the nicotinic acetylcholine receptor is inhibited by two distinct subpopulations of anti-receptor antibodies. Eur J Immunol 12:757–761
3. Barkas T, Simpson JA (1982) α-Bungarotoxin displacing antibody in myasthenia gravis. J Clin Lab Immunol 9:113–117
4. Barkas T, Simpson JA (1982) Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis. Clin Exp Immunol 47:119–126
5. DeCrousaz G, Fulpius B, Monnier V, Regli F (1978) Dosage des anticorps dirigés contre le récepteur nicotinique de l'acétylcholine: corrélations clinico-immunologiques chez 30 myasthéniques. Schweiz Med Wochenschr 108:602–607